We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Dose-Efficient X-Ray Imaging Method Produces Micrometer Resolution Images of Biopsy Samples

By LabMedica International staff writers
Posted on 20 Dec 2023
Print article
Image: Experimental setup of the dose-efficient X-ray imaging method (Photo courtesy of KIT)
Image: Experimental setup of the dose-efficient X-ray imaging method (Photo courtesy of KIT)

X-ray imaging plays a vital role in revealing the hidden structures and processes within living cells and organisms. However, the ionizing nature of X-ray radiation, composed of high-energy electromagnetic waves, poses a risk of damaging DNA, which in turn limits the duration of observation. Traditional X-ray imaging of soft tissues often results in low-contrast images, but phase contrast methods have been found to yield much clearer contrasts at lower radiation doses. However, achieving higher resolution in X-ray imaging is challenging due to the need for increased radiation dose, which is compounded by the reduced efficiency of high-resolution detectors, leading to further increase in radiation exposure. Until now, high-resolution X-ray phase contrast imaging of living biological samples could only be performed for a limited time before radiation caused significant damage.

At the Karlsruhe Institute of Technology (KIT, Karlsruhe, Germany), a team of researchers has innovated a technique that utilizes radiation more effectively and achieves micrometer-level resolution imaging. This method is suitable for observing both living organisms and delicate materials, opening new possibilities in fields like biology, biomedicine, and materials science. The novel system integrates X-ray phase contrast imaging with a Bragg magnifier and a photon-counting detector. In this setup, a photon-counting detector with 55-micrometer pixel size is used, and before capturing the specimen’s X-ray image, it is magnified using a Bragg magnifier. This magnification process allows the specimen's resolution to reach approximately 1 micrometer. The Bragg magnifier itself comprises two perfectly aligned silicon crystals, where the magnification effect is derived from asymmetric diffraction in the crystal lattice of silicon. A significant benefit of this Bragg magnifier is its exceptional optical image transmission, enabling almost complete replication of all spatial frequencies up to the resolution limit.

By combining propagation-based X-ray phase contrast with a Bragg magnifier and a photon-counting detector, all fine-tuned for 30 keV X-ray energy, the method achieves near-maximal dose efficiency for X-ray phase contrast imaging. This advancement permits extended observation periods of small living organisms with detailed micrometer resolution. The team showcased this technique in a preliminary study on tiny parasitic wasps, observing their activities inside host eggs and their emergence over more than 30 minutes. Future plans involve enhancing the setup to expand the field of view and boost mechanical stability, thereby enabling even longer measurement durations.

“Instead of converting the X-ray image into an image with visible light and enlarging it afterwards, we enlarge it directly,” said LAS doctoral researcher Rebecca Spiecker. “Thanks to this approach, we can use highly efficient large-area detectors. The method is also suited for biomedical applications, an example being the gentle three-dimensional histological investigation of biopsy samples.”

Related Links:
KIT

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The research team has developed the uCR-Chip device to enhance kidney function testing (Photo courtesy of University of Manitoba)

Low-Cost Portable Screening Test to Transform Kidney Disease Detection

Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.